Historical
Acquisition of ePocrates by athenahealth
| Name | Type | Mentions | |
|---|---|---|---|
| ePocrates, Inc. | organization | 6 | View Entity |
| athenahealth | organization | 4 | View Entity |
HOUSE_OVERSIGHT_024050.jpg
This document is page 39 of a confidential investment memorandum or fund report stamped by House Oversight. It details specific healthcare investment themes including Care Coordination, Clinical Error Reduction, and Analytics/Data-Driven Personalization, highlighting portfolio companies such as TigerText, ePocrates, iRhythm Technologies, and Treato. The document notes the financial success of ePocrates (acquired for $293 million) and attributes several companies to a fund designated as 'NLV-II'.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event